Takaoka K, Mott S, Yodsuwan R, Saowapa S, et al. KRAS Mutations Predict Inferior Post-Remission Outcomes in Newly Diagnosed Acute Myeloid Leukemia With MAPK Pathway Mutations. Eur J Haematol 2026 Jul 24. doi: 10.1111/ejh.70270.
PMID: 42498507